Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm
Personalized medicine: Signature-guided cancer therapy Personalized cancer therapy is one of the holy grails of oncology, as the ability to determine what treatment would best benefit a patient would serve not only to improve outcomes, but also mitigate side effects from less effective treatments. H...
Guardado en:
Autores principales: | Daniel J. McGrail, Curtis Chun-Jen Lin, Jeannine Garnett, Qingxin Liu, Wei Mo, Hui Dai, Yiling Lu, Qinghua Yu, Zhenlin Ju, Jun Yin, Christopher P. Vellano, Bryan Hennessy, Gordon B. Mills, Shiaw-Yih Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b2d7262023a5464f9e1788ca4d9c8cbf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
por: Daniel J. McGrail, et al.
Publicado: (2018) -
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
por: Hyoung Kim, et al.
Publicado: (2020) -
Data-Driven Anomaly Detection in High-Voltage Transformer Bushings with LSTM Auto-Encoder
por: Imene Mitiche, et al.
Publicado: (2021) -
Differential regulation of breast cancer bone metastasis by PARP1 and PARP2
por: Hao Zuo, et al.
Publicado: (2020) -
Serine-linked PARP1 auto-modification controls PARP inhibitor response
por: Evgeniia Prokhorova, et al.
Publicado: (2021)